{ "meta": { "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.", "terms": "https://open.fda.gov/terms/", "license": "https://open.fda.gov/license/", "last_updated": "2026-07-10", "results": { "skip": 0, "limit": 1, "total": 1 } }, "results": [ { "submissions": [ { "submission_type": "SUPPL", "submission_number": "4", "submission_status": "AP", "submission_status_date": "20180510", "review_priority": "STANDARD", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling", "application_docs": [ { "id": "54182", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/205836s005,205837s004,205838s003lbl.pdf", "date": "20180514", "type": "Label" }, { "id": "54202", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/205836Orig1s005,205837Orig1s004,205838Orig1s003ltr(2).pdf", "date": "20180516", "type": "Letter" } ] }, { "submission_type": "SUPPL", "submission_number": "14", "submission_status": "AP", "submission_status_date": "20250828", "review_priority": "STANDARD", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling", "application_docs": [ { "id": "83241", "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/205836Orig1s017, 205837Orig1s014, 205838Orig1s015ltr.pdf", "date": "20250829", "type": "Letter" }, { "id": "83261", "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/205836s017,205837s014,205838s015lbl.pdf", "date": "20250902", "type": "Label" }, { "id": "83262", "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/205836s017,205837s014,205838s015lbl.pdf#page=18", "date": "20250902", "type": "Medication Guide" } ] }, { "submission_type": "SUPPL", "submission_number": "9", "submission_status": "AP", "submission_status_date": "20210902", "review_priority": "STANDARD", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling", "application_docs": [ { "id": "68537", "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/205836Orig1s011;%20205837Orig1s009;%20205838Orig1s008ltr.pdf", "date": "20210903", "type": "Letter" }, { "id": "69601", "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/205836Orig1s011;205837Orig1s009;205838Orig1s008lbl.pdf", "date": "20211216", "type": "Label" } ] }, { "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20160218", "submission_public_notes": "FR Notice on DEA Scheduling; Date of Approval May 12, 2016", "review_priority": "STANDARD", "submission_class_code": "TYPE 3", "submission_class_code_description": "Type 3 - New Dosage Form", "application_docs": [ { "id": "43505", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2016/205836-205837-205838-Briviact-TOC.html", "date": "20160330", "type": "Review" }, { "id": "47888", "url": "https://www.federalregister.gov/documents/2016/05/12/2016-11245/schedules-of-controlled-substances-placement-of-brivaracetam-into-schedule-v", "date": "20170407", "type": "Federal Register Notice" }, { "id": "10515", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/0205836Orig1s000,0205837Orig1s000,0205838Orig1s000ltr.pdf", "date": "20160219", "type": "Letter" }, { "id": "19692", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/205836Orig1s000,205837Orig1s000,205838Orig1s000lbl.pdf", "date": "20160219", "type": "Label" } ] }, { "submission_type": "SUPPL", "submission_number": "7", "submission_status": "AP", "submission_status_date": "20210827", "review_priority": "STANDARD", "submission_class_code": "EFFICACY", "submission_class_code_description": "Efficacy", "application_docs": [ { "id": "68493", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/205836Orig1s009; 205837Orig1s007; 205838Orig1s006ltr.pdf", "date": "20210831", "type": "Letter" }, { "id": "68501", "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/205836s009,205837s007,205838s006lbl.pdf", "date": "20210831", "type": "Label" } ] }, { "submission_type": "SUPPL", "submission_number": "3", "submission_status": "AP", "submission_status_date": "20170914", "review_priority": "STANDARD", "submission_class_code": "EFFICACY", "submission_class_code_description": "Efficacy", "application_docs": [ { "id": "49740", "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/205836s003,205837s003,205838s002lbl.pdf", "date": "20170915", "type": "Label" }, { "id": "49794", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/205836s003,205837s003,205838s002ltr.pdf", "date": "20170919", "type": "Letter" } ] }, { "submission_type": "SUPPL", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20160603", "review_priority": "STANDARD", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling", "application_docs": [ { "id": "40516", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/205836s001,205837s001,205838s001lbl.pdf", "date": "20160606", "type": "Label" }, { "id": "32748", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/205836Orig1s001,205837Orig1s001,205838Orig1s001ltr.pdf", "date": "20160606", "type": "Letter" } ] }, { "submission_type": "SUPPL", "submission_number": "11", "submission_status": "AP", "submission_status_date": "20230517", "review_priority": "STANDARD", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling", "application_docs": [ { "id": "74289", "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205836s014,205837s011,205838s011lbl.pdf", "date": "20230518", "type": "Label" }, { "id": "74303", "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/205836Orig1s014;205837Orig1s011;205838Orig1s011ltr.pdf", "date": "20230518", "type": "Letter" } ] } ], "application_number": "NDA205837", "sponsor_name": "UCB INC", "openfda": { "application_number": [ "NDA205837" ], "brand_name": [ "BRIVIACT" ], "generic_name": [ "BRIVARACETAM" ], "manufacturer_name": [ "UCB, Inc." ], "product_ndc": [ "50474-970", "50474-470", "50474-370", "50474-570", "50474-670", "50474-770", "50474-870" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "INTRAVENOUS" ], "substance_name": [ "BRIVARACETAM" ], "rxcui": [ "1739749", "1739754", "1739761", "1739766", "1739768", "1739770", "1739772", "1739774", "1739776", "1739778", "1739780", "1739782", "1739785", "1739788" ], "spl_id": [ "51b3e2db-678a-dd8b-e063-6394a90aed7d" ], "spl_set_id": [ "3cf2f439-0e97-443e-8e33-25ecef616f6c" ], "package_ndc": [ "50474-470-66", "50474-470-09", "50474-470-14", "50474-370-66", "50474-570-66", "50474-570-09", "50474-570-14", "50474-670-66", "50474-770-66", "50474-770-09", "50474-770-14", "50474-870-15", "50474-970-63", "50474-970-75" ], "nui": [ "N0000192345" ], "pharm_class_moa": [ "Epoxide Hydrolase Inhibitors [MoA]" ], "unii": [ "U863JGG2IA" ] }, "products": [ { "product_number": "001", "reference_drug": "Yes", "brand_name": "BRIVIACT", "active_ingredients": [ { "name": "BRIVARACETAM", "strength": "50MG/5ML (10MG/ML)" } ], "reference_standard": "Yes", "dosage_form": "SOLUTION", "route": "INTRAVENOUS", "marketing_status": "Prescription", "te_code": "AP" } ] } ] }